Clearance Summary
CHARTER GUIDEWIRE received FDA 510(k) clearance under submission number K122856, sponsored by Brivant, Ltd.. The device was reviewed via the Special premarket notification pathway and assigned to the Cardiovascular review panel. The statutory decision date of record is 2012-10-17.
- Submission: K122856
- Applicant / Sponsor: Brivant, Ltd.
- Clearance pathway: Special
- Review panel: Cardiovascular
- Device class: Class II
- Regulation citation: 21 CFR 870.1330
- Decision date: 2012-10-17
Classification & Regulation
This clearance is catalogued under FDA product code DQX and 21 CFR 870.1330, within the Cardiovascular review panel as a Class II device.